Skip to main content
. 2017 Oct 26;12(10):e0187086. doi: 10.1371/journal.pone.0187086

Fig 5. CD3+ T-lymphocytes in tumor-draining lymph nodes.

Fig 5

A) Volume density of CD3+ T-lymphocytes in regional lymph nodes (LNs) at different time points post injection of vehicle, AT1-, or MLL tumor cells into the ventral prostate (bars represent mean +/- SD, n = 7–8 animals/group, * p < 0.05). B) Representative sections showing CD3 staining (brown) of vehicle-, AT1- and MLL-LNs at day 3 and 7 (two different magnifications) compared to treatment-naïve LNs (insert shows control staining without primary antibody).